© Velar Grant / Global Look Press
27 July, 2018
Home Secretary, Sajid Javid, announced that cannabis-derived medicines should be placed in schedule 2 of the 2001 Misuse of Drugs Regulations, potentially allowing thousands of suffers from various diseases the chance of relief.
Previously a schedule 1 drug, cannabis was considered – despite numerous scientific studies to the contrary – to have no therapeutic value. It’s only permitted legal use was for research purposes.
The move follows increased public and professional pressure for a change in law. The exposure of high profile cases, including that of epilepsy suffering 12-year-old Billy Caldwell, led to a government review. The government’s official drug advisers, along with the chief medical officer for Britain, argued that there was evidence that cannabis provided therapeutic benefit for some conditions.
Prime Minister Theresa May was reportedly against the review taking place, though Javid told parliament that should benefits be identified he would follow the review’s advise.
There are no government plans to legalize the drug for recreational use.
PM’s Husband Philip May’s Capital Group profits from British weed-growing op while patients denied access (VIDEO)
The accusations first surfaced in an article by Dr John Regan, published in April by the website urhealthguide.com, using data provided by cannabis advocacy groups Transform and Cardiff Cannabis Cafe, which accused the government of hypocrisy for its stance on medicinal cannabis.